Anna Kazanchyan's Net Worth
$153 Thousand
Who is Anna Kazanchyan?
Anna Kazanchyan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NAREK PHARMACEUTICALS, HERATSI PHARMACEUTICALS, Foamix Pharmaceuticals Ltd., and INNOVATE BIOPHARMACEUTICALS, INC..
SEC CIK
Anna Kazanchyan's CIK is 0001369219
Past Insider Trading and Trends
2018 was Anna Kazanchyan's most active year for acquiring shares with 1 total transactions. Anna Kazanchyan's most active month to acquire stocks was the month of April. 2020 was Anna Kazanchyan's most active year for disposing of shares, totalling 4 transactions. Anna Kazanchyan's most active month to dispose stocks was the month of February. 2019 saw Anna Kazanchyan paying a total of $0.00 for 28,195 shares, this is the most they've acquired in one year. In 2007 Anna Kazanchyan cashed out on 28,000,000 shares for a total of $100,800.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NAREK PHARMACEUTICALS No price found
President, SecretaryAnna Kazanchyan used to own units in Common Stock, par value $.0001 per share(the "Common Stock") but no longer holds any shares there.disposed a total of 14,000,000 shares of NAREK PHARMACEUTICALS equalling to $50,400.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.00M |
—
| -$50,400.00 |
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERATSI PHARMACEUTICALS No price found
President, SecretaryAnna Kazanchyan used to own units in Common Stock, par value $.0001 per share(the "Common Stock") but no longer holds any shares there.disposed a total of 14,000,000 shares of HERATSI PHARMACEUTICALS equalling to $50,400.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -14.00M |
—
| -$50,400.00 |
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foamix Pharmaceuticals Ltd. No price found
InvestorAnna Kazanchyan used to own units in Ordinary Shares but no longer holds any shares there. In the year 2018 Anna Kazanchyan filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -58.74K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +56.66% | 21.25K |
—
|
—
| 58.74K |
Feb 27
| |||
Form 4
| -15.82% | -7.05K |
$3.27 | -$23,050.23 | 37.5K |
Aug 26
| |||
Form 4
| -1.78% | -808.00 |
$2.31 | -$1,866.48 | 44.55K |
Scheduled
|
Jul 15
| ||
Form 4
| +63.38% | 17.59K |
$2.61 | -$27,666.00 | 45.35K |
Scheduled
|
May 16 - May 20
| ||
Form 4
| +114.68% | 14.83K |
—
|
—
| 27.76K |
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INNOVATE BIOPHARMACEUTICALS, INC. (NMTRQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||